Edwards Lifesciences | EW - Zahlungsmittel Und Äquivalente

Aktienkurs
81.22
Täglich Wechseln
-1.06 -1.29%
Monatlich
2.16%
Jährlich
7.59%
Q2 Prognose
82.35




Zahlungsmittel Und Äquivalente Veränderung Datum
Abbott USD 6.8B 1.72B 2026-03
Artivion USD 64.91M 8.52M 2025-12
AtriCure USD 167.43M 19.56M 2025-12
Baxter International USD 1.97B 240M 2025-12
Becton, Dickinson and Co. USD 740M 99M 2025-12
Boston Scientific USD 1.96B 690M 2025-12
Cooper Companies USD 110.6M 14.3M 2025-09
Dexcom USD 917.7M 918M 2025-12
Edwards Lifesciences USD 2.4B 538M 2026-03
Globus Medical USD 526.16M 154.39M 2025-12
ICU Medical USD 307.96M 8.23M 2025-12
Inogen USD 106.48M 2.79M 2025-09
Insulet USD 716.1M 41.3M 2025-12
Integra LifeSciences USD 235.05M 2.86M 2025-12
Intuitive Surgical USD 7.98B 1.05B 2026-03
J&J USD 21.69B 1.98B 2026-03
Masimo USD 312.3M 162.7M 2025-09
Medtronic USD 1.15B 135M 2025-12
Merit Medical Systems USD 446.4M 53.95M 2025-12
Stryker USD 4.01B 755M 2025-12
Tandem Diabetes Care USD 90.63M 1.31M 2025-12
Teleflex USD 354M 100.3M 2025-09
Zimmer Biomet Holdings USD 591.9M 700.8M 2025-12